Optimizing the Novel Multiplexing Biomarker Paradigm to Support Clinical Studies
Time: 11:35 am
day: Day Three Track A
Details:
- Introduction of special based novel multiplexing paradigm to evaluate tumor and tumor microenvironment (apply both RNA and protein expression on one tissue slide if data available)
- Optimization of the testing panel including the multiplexing assay procedure and result assessment
- Selection of the multiplex paradigm to best support clinical studies
